Audited Supplier
0.4ml and 0.6ml
Internal Medicine
Ih
Elderly, Adult
Liquid
Injection
Organic Chemicals
Chemical Synthesis
Enoxaparin Sodium
USP
Prefilled Syringe in Box and Carton
0.4ml: 4000AxaIU and 0.6ml: 6000AxaIU
P. R. China
3004909099
Product Description
It is indicated for the prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE):in patients undergoing abdominal surgery who are at risk for thromboembolic complications;
in patients undergoing hip replacement surgery, during and following hospitalization;
in patients undergoing knee replacement surgery;
in medical patients who are at risk for thromboembolic complications due to severely restricted mobility during acute illness;
Treatment Of Acute Deep Vein Thrombosis:
the inpatient treatment of acute deep vei
n thrombosis with or without pulmonary embolism, when administered in conjunction with warfarin sodium;
the outpatient treatment of acute deep vein thrombosis without pulmonary embolism when administered in conjunction with warfarin sodium;
It is indicated for the prophylaxis of ischemic complications of unstable angina and non- Q-wave myocardial infarction, when concurrently administered with aspirin.when administered concurrently with aspirin, has been shown to reduce the rate of the combined endpoint of recurrent myocardial infarction or death in patients with acute ST-segment elevation myocardial infarction (STEMI) receiving thrombolysis and being managed medically or with percutaneous coronary intervention (PCI).
